4,366
Views
97
CrossRef citations to date
0
Altmetric
Original Research

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

, , , , , , & ORCID Icon show all
Article: e1593805 | Received 07 Dec 2018, Accepted 28 Feb 2019, Published online: 24 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Malgorzata Czystowska-Kuzmicz & Theresa L. Whiteside. (2021) The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer. Expert Opinion on Biological Therapy 21:2, pages 241-258.
Read now
Wang Gong, Christopher R. Donnelly, Blake R. Heath, Emily Bellile, Lorenza A. Donnelly, Hülya F. Taner, Luke Broses, J. Chad Brenner, Steven B. Chinn, Ru-Rong Ji, Haitao Wen, Jacques E. Nör, Jie Wang, Gregory T. Wolf, Yuying Xie & Yu Leo Lei. (2021) Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion. OncoImmunology 10:1.
Read now
Wen-Ying Yang, Lin-Fei Feng, Xiang Meng, Ran Chen, Wen-Hua Xu, Jun Hou, Tao Xu & Lei Zhang. (2020) Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes. Expert Review of Molecular Diagnostics 20:12, pages 1213-1227.
Read now
Amy Makler & Waseem Asghar. (2020) Exosomal biomarkers for cancer diagnosis and patient monitoring. Expert Review of Molecular Diagnostics 20:4, pages 387-400.
Read now
Marie-Nicole Theodoraki, Akihiro Matsumoto, Inga Beccard, Thomas K. Hoffmann & Theresa L. Whiteside. (2020) CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients’ plasma as potential noninvasive biomarkers of disease activity. OncoImmunology 9:1.
Read now

Articles from other publishers (91)

Karama Asleh, Valerie Dery, Catherine Taylor, Michelle Davey, Marie-Ange Djeungoue-Petga & Rodney J. Ouellette. (2023) Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology. Biomarker Research 11:1.
Crossref
Yonghong Cheng, Feiyun Chang, Yanmei Gong & Ping Lu. (2023) A Study on the Clinical Significance of Blood Exosomal PD-L1 in Non-Small Cell Lung Cancer Patients and its Correlation with PD-L1 in Tumor Tissues. Hormone and Metabolic Research 55:11, pages 788-793.
Crossref
María Celeste Nicolao, Christian Rodriguez Rodrigues, Magalí B. Coccimiglio, Camila Ledo, Guillermo H. Docena & Andrea C. Cumino. (2023) Characterization of protein cargo of Echinococcus granulosus extracellular vesicles in drug response and its influence on immune response. Parasites & Vectors 16:1.
Crossref
Annette Affolter, Kai Liebel, Luisa Tengler, Elena Seiz, Moritz Tiedtke, Alexya Azhakesan, Julia Schütz, Marie-Nicole Theodoraki, Johann Kern, Arne Ruder, Jens Fleckenstein, Cleo-Aron Weis, Karen Bieback, Benedikt Kramer, Anne Lammert, Claudia Scherl, Nicole Rotter & Sonja Ludwig. (2023) Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes. International Journal of Oncology 63:3.
Crossref
Michael M. Allevato, Joshua D. Smith, Michael J. Brenner & Steven B. Chinn. (2023) Tumor-Derived Exosomes and the Role of Liquid Biopsy in Human Papillomavirus Oropharyngeal Squamous Cell Carcinoma. The Cancer Journal 29:4, pages 230-237.
Crossref
Jingwen Xiong, Hao Chi, Guanhu Yang, Songyun Zhao, Jing Zhang, Lisa Jia Tran, Zhijia Xia, Fang Yang & Gang Tian. (2023) Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes. Frontiers in Immunology 14.
Crossref
Qiujun Zhou, Shenyu Wei, Hui Wang, Yuanyuan Li, Shasha Fan, Yi Cao & Chenglei Wang. (2023) T cell-derived exosomes in tumor immune modulation and immunotherapy. Frontiers in Immunology 14.
Crossref
Chris Y. Chiu, Maya D. Schou, James H. McMahon, Steven G. Deeks, Rémi Fromentin, Nicolas Chomont, Michelle N. Wykes, Thomas A. Rasmussen & Sharon R. Lewin. (2023) Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy. Frontiers in Immunology 14.
Crossref
Barnabas Irmer, Suganja Chandrabalan, Lukas Maas, Annalen Bleckmann & Kerstin Menck. (2023) Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors. Cancers 15:4, pages 1307.
Crossref
Haojie Wang, Yijun Qi, Zijun Lan, Qiwei Liu, Juanjuan Xu, Mengxi Zhu, Tingting Yang, Ruolin Shi, Shegan Gao & Gaofeng Liang. (2022) Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21. Gene Therapy 30:1-2, pages 88-100.
Crossref
Shayista Akbar, Afsheen Raza, Reyad Mohsin, Aladdin Kanbour, Shahnaz Qadri, Aijaz Parray, Abdul Rehman Zar Gul, Anite Philip, Suma Vijayakumar, Maysaloun Merhi, Shereena Hydrose, Varghese Philipose Inchakalody, Rajaa Al-Abdulla, Wafa Abualainin, Shaza Abu Sirriya, Issam Al-Bozom, Shahab Uddin, Omar Muhammad Khan, Mohamed Izham Mohamed Ibrahim, Ussama Al Homsi & Said Dermime. (2023) Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients. Frontiers in Immunology 13.
Crossref
Despoina Papaioannou, Spyridoula Petsali, Alida Ndreou, Fani Akritidou, Vasileios Zisis, Dimitrios Kavvadas, Athanasios Poulopoulos, Sofia Karachrysafi & Dimitrios Andreadis. (2023) Immunotherapy in oral cancer: Review. Balkan Journal of Dental Medicine 27:3, pages 129-139.
Crossref
Alfredo Tartarone, Rosa Lerose, Marina Tartarone & Michele Aieta. (2022) Potential Role of Tumor-Derived Exosomes in Non-Small-Cell Lung Cancer in the Era of Immunotherapy. Life 12:12, pages 2104.
Crossref
Julie Joseph, Benjamin Rahmani, Yonesha Cole, Neha Puttagunta, Edward Lin, Zafar K. Khan & Pooja Jain. (2021) Can Soluble Immune Checkpoint Molecules on Exosomes Mediate Inflammation?. Journal of Neuroimmune Pharmacology 17:3-4, pages 381-397.
Crossref
Qiurong Yang, Jing Xu, Jianmei Gu, Hui Shi, Jiayin Zhang, Jianye Zhang, Zhe‐Sheng Chen, Xinjian Fang, Taofeng Zhu & Xu Zhang. (2022) Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. Advanced Science 9:34.
Crossref
Antonia Reale, Tiffany Khong & Andrew Spencer. (2022) Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment. Journal of Clinical Medicine 11:23, pages 6892.
Crossref
Pingping Han & Sašo Ivanovski. (2022) 3D bioprinted extracellular vesicles for tissue engineering - a perspective. Biofabrication.
Crossref
Diego Signorelli, Patrizia Ghidotti, Claudia Proto, Marta Brambilla, Alessandro De Toma, Roberto Ferrara, Giulia Galli, Monica Ganzinelli, Giuseppe Lo Russo, Arsela Prelaj, Mario Occhipinti, Giuseppe Viscardi, Valentina Capizzuto, Francesca Pontis, Ilaria Petraroia, Anna Maria Ferretti, Mario Paolo Colombo, Valter Torri, Gabriella Sozzi, Marina Chiara Garassino, Elena Jachetti & Orazio Fortunato. (2022) Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC. Frontiers in Immunology 13.
Crossref
Simona Bernardi, Mirko Farina, Katia Bosio, Anna Di Lucanardo, Alessandro Leoni, Federica Re, Nicola Polverelli, Alessandro Turra, Enrico Morello, Eugenia Accorsi Buttini, Tatiana Zollner, Cristian Bonvicini, Michele Malagola & Domenico Russo. (2022) Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection. Cancers 14:18, pages 4504.
Crossref
Xia Wang, Lu Tian, Jingyi Lu & Irene Oi-Lin Ng. (2022) Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle. Oncogenesis 11:1.
Crossref
Seyed Ziaeddin Rasihashemi, Hadi Sahrai, Erfan Rezazadeh-Gavgani, Yalda Yazdani, Amirreza Khalaji & Parisa Lotfinejad. (2022) Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment. Medical Oncology 39:12.
Crossref
Siqing Jiang, Xin Li, Lihua Huang, Zhensheng Xu & Jinguan Lin. (2022) Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer. Frontiers in Immunology 13.
Crossref
Mariana Chantre-Justino, Gilda Alves & Lucas Delmonico. (2022) Clinical applications of liquid biopsy in HPV‐negative and HPV‐positive head and neck squamous cell carcinoma: advances and challenges. Exploration of Targeted Anti-tumor Therapy, pages 533-552.
Crossref
Tatiana Lopatina, Alessandro Sarcinella & Maria Felice Brizzi. (2022) Tumour Derived Extracellular Vesicles: Challenging Target to Blunt Tumour Immune Evasion. Cancers 14:16, pages 4020.
Crossref
Jianyun Jiang & Hongmei Ying. (2022) Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Zi-Li Yu, Jin-Yuan Liu & Gang Chen. (2022) Small extracellular vesicle PD-L1 in cancer: the knowns and unknowns. npj Precision Oncology 6:1.
Crossref
Alessandro Del Conte, Elisa De Carlo, Elisa Bertoli, Brigida Stanzione, Alberto Revelant, Manuela Bertola, Michele Spina & Alessandra Bearz. (2022) Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications. International Journal of Molecular Sciences 23:12, pages 6832.
Crossref
Aneta Zebrowska, Karol Jelonek, Sujan Mondal, Marta Gawin, Katarzyna Mrowiec, Piotr Widłak, Theresa Whiteside & Monika Pietrowska. (2022) Proteomic and Metabolomic Profiles of T Cell-Derived Exosomes Isolated from Human Plasma. Cells 11:12, pages 1965.
Crossref
Ting Li, Juan Li, Haitao Wang, Jiayu Zhao, Mingze Yan, Hongjiang He & Shan Yu. (2022) Exosomes: Potential Biomarkers and Functions in Head and Neck Squamous Cell Carcinoma. Frontiers in Molecular Biosciences 9.
Crossref
Santiago Cabezas-Camarero & Pedro Pérez-Segura. (2022) Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers. Cancers 14:12, pages 2858.
Crossref
Yang Li, Shengtao Gao, Qi Hu & Fanglong Wu. (2022) Functional Properties of Cancer Epithelium and Stroma-Derived Exosomes in Head and Neck Squamous Cell Carcinoma. Life 12:5, pages 757.
Crossref
Xiaoyan Dou, Yan Hua, Zhaowu Chen, Fengmei Chao & Ming Li. (2022) Extracellular vesicles containing PD-L1 contribute to CD8+ T-cell immune suppression and predict poor outcomes in small cell lung cancer. Clinical and Experimental Immunology 207:3, pages 307-317.
Crossref
Catarina M. Abreu, Bruno Costa-Silva, Rui L. Reis, Subhas C. Kundu & David Caballero. (2022) Microfluidic platforms for extracellular vesicle isolation, analysis and therapy in cancer. Lab on a Chip 22:6, pages 1093-1125.
Crossref
Seyed Z. Rasihashemi, Erfan Rezazadeh Gavgani, Reza Majidazar, Parya Seraji, Mobina Oladghaffari, Tohid Kazemi & Parisa Lotfinejad. (2021) Tumor‐derived exosomal PD‐L1 in progression of cancer and immunotherapy. Journal of Cellular Physiology 237:3, pages 1648-1660.
Crossref
Vasudha Mishra, Alka Singh, Xiangying Chen, Ari J. Rosenberg, Alexander T. Pearson, Alex Zhavoronkov, Peter A. Savage, Mark W. Lingen, Nishant Agrawal & Evgeny Izumchenko. (2021) Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. British Journal of Cancer 126:3, pages 361-370.
Crossref
Valentin Van den bossche, Hannah Zaryouh, Marianela Vara-Messler, Julie Vignau, Jean-Pascal Machiels, An Wouters, Sandra Schmitz & Cyril Corbet. (2022) Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Drug Resistance Updates 60, pages 100806.
Crossref
M.-N. Theodoraki, S. Laban, E. K. Jackson, R. Lotfi, P. J. Schuler, C. Brunner, T. K. Hoffmann, T. L. Whiteside & L. Hofmann. (2021) Changes in circulating exosome molecular profiles following surgery/(chemo)radiotherapy: early detection of response in head and neck cancer patients. British Journal of Cancer 125:12, pages 1677-1686.
Crossref
Jiayue Yang, Cheng Yang, Hong Shen, Wenjun Wu, Zhen Tian, Qinghua Xu, Cuiping Cao, Shugao Ye, Le Ban, Xin Tong & Jie Mei. (2021) Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients. Cancer Cell International 21:1.
Crossref
Metka Sluga, Saba Battelino & Domen Vozel. (2021) Prospects of Extracellular Vesicles in Otorhinolaryngology, Head and Neck Surgery. Journal of Nanotheranostics 2:4, pages 208-223.
Crossref
Chang Liu, Miao Wang, Changli Xu, Bo Li, Juxiang Chen, Jianchun Chen & Zhiwei Wang. (2021) Immune Checkpoint Inhibitor Therapy for Bone Metastases: Specific Microenvironment and Current Situation. Journal of Immunology Research 2021, pages 1-18.
Crossref
Cheng Xing, Heng Li, Rui-Juan Li, Le Yin, Hui-Fang Zhang, Zi-Neng Huang, Zhao Cheng, Ji Li, Zhi-Hua Wang & Hong-Ling Peng. (2021) The roles of exosomal immune checkpoint proteins in tumors. Military Medical Research 8:1.
Crossref
Bo Shao, Qin Dang, Zhuang Chen, Chen Chen, Quanbo Zhou, Bingbing Qiao, Jinbo Liu, Shengyun Hu, Guixian Wang, Weitang Yuan & Zhenqiang Sun. (2021) Effects of Tumor-Derived Exosome Programmed Death Ligand 1 on Tumor Immunity and Clinical Applications. Frontiers in Cell and Developmental Biology 9.
Crossref
Kittinun Leetanaporn, Jitti Hanprasertpong & Raphatphorn Navakanitworakul. (2021) Molecular insights and clinical impacts of extracellular vesicles in cancer. Oncology Reviews 2:15.
Crossref
Valentin Vautrot, Hafidha Bentayeb, Sébastien Causse, Carmen Garrido & Jessica Gobbo. (2021) Tumor-Derived Exosomes: Hidden Players in PD-1/PD-L1 Resistance. Cancers 13:18, pages 4537.
Crossref
Elena Muraro, Giuseppe Fanetti, Valentina Lupato, Vittorio Giacomarra, Agostino Steffan, Carlo Gobitti, Emanuela Vaccher & Giovanni Franchin. (2021) Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistance. Critical Reviews in Oncology/Hematology 164, pages 103424.
Crossref
Vivian Weiwen Xue, Chenxi Yang, Sze Chuen Cesar Wong & William Chi Shing Cho. (2021) Proteomic profiling in extracellular vesicles for cancer detection and monitoring. PROTEOMICS 21:13-14.
Crossref
Theresa L. Whiteside, Brenda Diergaarde & Chang-Sook Hong. (2021) Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology. International Journal of Molecular Sciences 22:12, pages 6234.
Crossref
E Zhou, Yumei Li, Feng Wu, Mengfei Guo, Juanjuan Xu, Sufei Wang, Qi Tan, Pei Ma, Siwei Song & Yang Jin. (2021) Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy. EBioMedicine 67, pages 103365.
Crossref
Eleni-Kyriaki Vetsika, Priyanka Sharma, Ioannis Samaras, Alexandra Markou, Vassilis Georgoulias, Theresa L. Whiteside & Athanasios Kotsakis. (2021) Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients. Cancers 13:9, pages 2041.
Crossref
Lingyi Kong & Andrew C. Birkeland. (2021) Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges. Cancers 13:8, pages 1874.
Crossref
Ya-Nan Pi, Bai-Rong Xia, Ming-Zhu Jin, Wei-Lin Jin & Ge Lou. (2021) Exosomes: Powerful weapon for cancer nano-immunoengineering. Biochemical Pharmacology 186, pages 114487.
Crossref
Florencia Veigas, Yamil D. Mahmoud, Joaquin Merlo, Adriana Rinflerch, Gabriel Adrian Rabinovich & María Romina Girotti. (2021) Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma. Cancers 13:5, pages 1018.
Crossref
Masayoshi Saito, Satoshi Horie, Hidenori Yasuhara, Akane Kashimura, Eiji Sugiyama, Takeaki Saijo, Hajime Mizuno, Hiroshi Kitajima & Kenichiro Todoroki. (2021) Metabolomic profiling of urine-derived extracellular vesicles from rat model of drug-induced acute kidney injury. Biochemical and Biophysical Research Communications 546, pages 103-110.
Crossref
Jonalyn DeCastro, Joshua Littig, Peichi Peggy Chou, Jada Mack-Onyeike, Amrita Srinivasan, Michael J. Conboy, Irina M. Conboy & Kiana Aran. (2021) The Microfluidic Toolbox for Analyzing Exosome Biomarkers of Aging. Molecules 26:3, pages 535.
Crossref
Tamiem Adam, Therese M. Becker, Wei Chua, Victoria Bray & Tara L. Roberts. (2021) The Multiple Potential Biomarkers for Predicting Immunotherapy Response—Finding the Needle in the Haystack. Cancers 13:2, pages 277.
Crossref
Zi Yin, Min Yu, Tingting Ma, Chuanzhao Zhang, Shanzhou Huang, Mohammad Reza Karimzadeh, Amir Abaas Momtazi-Borojeni & Sheng Chen. (2021) Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1. Journal for ImmunoTherapy of Cancer 9:1, pages e001698.
Crossref
Marzia Del Re, Ron H.N. van Schaik, Stefano Fogli, Ron H.J. Mathijssen, Federico Cucchiara, Annalisa Capuano, Cristina Scavone, Guido W. Jenster & Romano Danesi. (2021) Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1875:1, pages 188463.
Crossref
Antonia Schubert & Michael Boutros. (2020) Extracellular vesicles and oncogenic signaling. Molecular Oncology 15:1, pages 3-26.
Crossref
Zhijie Xu, Shuangshuang Zeng, Zhicheng Gong & Yuanliang Yan. (2020) Exosome-based immunotherapy: a promising approach for cancer treatment. Molecular Cancer 19:1.
Crossref
Theresa L. Whiteside. (2020) Validation of plasma-derived small extracellular vesicles as cancer biomarkers. Nature Reviews Clinical Oncology 17:12, pages 719-720.
Crossref
M.-N. Theodoraki & S. Ludwig. (2020) Exosomen: potenzielle Flüssigbiopsie bei Kopf-Hals-KarzinomenExosomes: potential liquid biopsy in head and neck cancer. best practice onkologie 15:12, pages 520-526.
Crossref
M. Wallesch, M. Wirth & B. Wollenberg. (2020) „Liquid biopsy“ als Schlüsselfigur in der ImmunonkologieLiquid biopsy—a possible key player in immuno-oncology. HNO 68:12, pages 899-904.
Crossref
Xinyu Qu, Jing-Woei Li, Jason Chan & Katie Meehan. (2020) Extracellular Vesicles in Head and Neck Cancer: A Potential New Trend in Diagnosis, Prognosis, and Treatment. International Journal of Molecular Sciences 21:21, pages 8260.
Crossref
Daniel S. K. Liu, Flora M. Upton, Eleanor Rees, Christopher Limb, Long R. Jiao, Jonathan Krell & Adam E. Frampton. (2020) Size-Exclusion Chromatography as a Technique for the Investigation of Novel Extracellular Vesicles in Cancer. Cancers 12:11, pages 3156.
Crossref
Sergi Benavente, Almudena Sánchez-García, Silvia Naches, Matilde Esther LLeonart & Juan Lorente. (2020) Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies. Frontiers in Oncology 10.
Crossref
Ancuta Jurj, Cecilia Pop-Bica, Ondrej Slaby, Cristina Ştefan, William C. Cho, Schuyler Korban & Ioana Berindan-Neagoe. (2020) Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer. International Journal of Molecular Sciences 21:20, pages 7688.
Crossref
Kaijian Zhou, Shu Guo, Fei Li, Qiang Sun & Guoxin Liang. (2020) Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies. Frontiers in Cell and Developmental Biology 8.
Crossref
Yiling Meng, Lei Bian, Meichao Zhang, Fang Bo, Xiao Lu & Dong Li. (2020) Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs. Biomarkers in Medicine 14:14, pages 1393-1404.
Crossref
S. Ludwig, N. Rotter, M.-N. Theodoraki, J. Jablonska, A. Lammert & S. Lang. (2020) Exosomen als Immunregulatoren in Kopf-Hals-KarzinomenExosomes as immune regulators in head and neck cancer. HNO 68:10, pages 719-725.
Crossref
Jan C. Schroeder, Lisa Puntigam, Linda Hofmann, Sandra S. Jeske, Inga J. Beccard, Johannes Doescher, Simon Laban, Thomas K. Hoffmann, Cornelia Brunner, Marie-Nicole Theodoraki & Patrick J. Schuler. (2020) Circulating Exosomes Inhibit B Cell Proliferation and Activity. Cancers 12:8, pages 2110.
Crossref
Matthew C. Knox, Jie Ni, Andrej Bece, Joseph Bucci, Yaw Chin, Peter H. Graham & Yong Li. (2020) A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications. Frontiers in Immunology 11.
Crossref
Inga J. Beccard, Linda Hofmann, Jan C. Schroeder, Sonja Ludwig, Simon Laban, Cornelia Brunner, Ramin Lotfi, Thomas K. Hoffmann, Edwin K. Jackson, Patrick J. Schuler & Marie-Nicole Theodoraki. (2020) Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer. Cancers 12:7, pages 1997.
Crossref
Reem Saleh & Eyad Elkord. (2020) Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy. Vaccines 8:3, pages 390.
Crossref
Samantha M. Morrissey & Jun Yan. (2020) Exosomal PD-L1: Roles in Tumor Progression and Immunotherapy. Trends in Cancer 6:7, pages 550-558.
Crossref
Linda Hofmann, Sonja Ludwig, Julius M. Vahl, Cornelia Brunner, Thomas K. Hoffmann & Marie-Nicole Theodoraki. (2020) The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer. International Journal of Molecular Sciences 21:11, pages 4072.
Crossref
Linda Hofmann, Sonja Ludwig, Patrick J. Schuler, Thomas K. Hoffmann, Cornelia Brunner & Marie-Nicole Theodoraki. (2020) The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer. International Journal of Molecular Sciences 21:11, pages 3739.
Crossref
Stefania Raimondo, Marzia Pucci, Riccardo Alessandro & Simona Fontana. (2020) Extracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical Perspectives. International Journal of Molecular Sciences 21:7, pages 2286.
Crossref
Etti Ester Azulay, Tomer Cooks & Moshe Elkabets. (2020) Potential oncogenic roles of mutant-p53-derived exosomes in the tumor–host interaction of head and neck cancers. Cancer Immunology, Immunotherapy 69:2, pages 285-292.
Crossref
Marie-Nicole Theodoraki & Sonja Ludwig. (2020) Exosomen: potenzielle Flüssigbiopsie bei Kopf-Hals-KarzinomenExosomes: potential liquid biopsy in head and neck cancer. HNO 68:2, pages 106-110.
Crossref
L. Muller. (2020) Exosomen: Nanostaub?Exosomes: Nanodust? German version. HNO 68:2, pages 111-114.
Crossref
Andrea K. Miyahira, Adam Sharp, Leigh Ellis, Jennifer Jones, Salma Kaochar, H. Benjamin Larman, David A. Quigley, Huihui Ye, Jonathan W. Simons, Kenneth J. Pienta & Howard R. Soule. (2019) Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting. The Prostate 80:2, pages 113-132.
Crossref
Priyanka Sharma, Brenda Diergaarde, Soldano Ferrone, John M. Kirkwood & Theresa L. Whiteside. (2020) Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells. Scientific Reports 10:1.
Crossref
Ines Stevic, Gustav Buescher & Franz Lennard Ricklefs. (2020) Monitoring Therapy Efficiency in Cancer through Extracellular Vesicles. Cells 9:1, pages 130.
Crossref
Sheila Spada, Nils-Petter Rudqvist & Erik Wennerberg. 2020. Tumor Immunology and Immunotherapy – Integrated Methods Part B. Tumor Immunology and Immunotherapy – Integrated Methods Part B 173 183 .
Sheila Spada & Lorenzo Galluzzi. 2020. Extracellular vesicles. Extracellular vesicles xv xviii .
Nicole C. Schmitt & Robert L. Ferris. 2020. Novel Therapies in Head and Neck Cancer: Beyond the Horizon. Novel Therapies in Head and Neck Cancer: Beyond the Horizon 117 142 .
L. Muller. (2020) Exosomes: nanodust?Exosome: Nanostaub?. HNO 68:S1, pages 56-59.
Crossref
Feiting Xie, Mengxue Xu, Jian Lu, Lingxiang Mao & Shengjun Wang. (2019) The role of exosomal PD-L1 in tumor progression and immunotherapy. Molecular Cancer 18:1.
Crossref
M. Helena Vasconcelos, Hugo R. Caires, Artūrs Ābols, Cristina P.R. Xavier & Aija Linē. (2019) Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance. Drug Resistance Updates 47, pages 100647.
Crossref
Jie Ni, Joseph Bucci, David Malouf, Matthew Knox, Peter Graham & Yong Li. (2019) Exosomes in Cancer Radioresistance. Frontiers in Oncology 9.
Crossref
Theresa L. Whiteside. (2019) Proteomic Analysis of Plasma-Derived Exosomes in Defining Their Role as Biomarkers of Disease Progression, Response to Therapy and Outcome. Proteomes 7:3, pages 27.
Crossref